Skip to main content
# Title Department Research Member Research Year
471 The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
Department of Clinical Pathology Dr. Asmaa Mohamed Zahran Omar 2019
472 Assesment OF complement regulatory protients CD55 and CD59 on erythocytes in Betathalassemia major patients Department of Clinical Pathology Dr. Iman Hassan Ahmed Hamada 2019
473 Prognostic Significance of Absolute
Lymphocytic Count Recovery in Pediatric
Patients with Acute Lymphoblastic Leukemia at
South Egypt Cancer Institute
Department of Clinical Pathology Dr. Noha gaber sayed 2019
474 The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
Department of Medical Oncology Prof. Ashraf Zeidan Abdalla Ahmed 2019
475 Prognostic Value of c-Myc Immunohistochemical Expression in Muscle Invasive Urothelial Carcinoma of the Urinary Bladder: A Retrospective Study
Department of Medical Oncology Dr. Ahmed Refaat Abdel Zaher Mubarak 2019
476 The Prognostic Implication of CD49d Expression by Flow Cytometry and Trisomy 12 Detection by Fluorescent in situ Hybridization in Chronic Lymphocytic Leukemia Department of Clinical Pathology Assmaa Ahmed Mohamed 2019
477 Immunohistochemical study of folate receptor-α and mammalian
target of rapamycin in endometrial hyperplasia and
endometrioid endometrial carcinoma


Department of Radiotherapy and Nuclear medicine Dr. Asmaa elsayed abdelsalam /hasaballah 2019
478 The Prognostic Implication of CD49d Expression by Flow Cytometry and Trisomy 12 Detection by Fluorescent in situ Hybridization in Chronic Lymphocytic Leukemia Department of Medical Oncology Dr. Mayada Fawzy Sedik Farghaly 2019
479 Correlation Between the Overall Disease Prognosis and The Percentage of Both (Trisomy 12 and CD49d Expression) in Patients with Chronic Lymphocytic Leukemia (CLL)
Department of Clinical Pathology Prof. Eman Massad Zaki El-Hefny 2019
480 Circulating hematopoietic stem cells, endothelial
progenitor cells and cancer stem cells in
hepatocellular carcinoma patients: contribution to
diagnosis and prognosis
Department of Clinical Pathology Dr. Asmaa Mohamed Zahran Omar 2019